| EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity J Bieschke, J Russ, RP Friedrich, DE Ehrnhoefer, H Wobst, ... Proceedings of the National Academy of Sciences 107 (17), 7710-7715, 2010 | 1088 | 2010 |
| Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils J Bieschke, M Herbst, T Wiglenda, RP Friedrich, A Boeddrich, F Schiele, ... Nature chemical biology 8 (1), 93-101, 2012 | 487 | 2012 |
| Magnetic nanoparticle-based drug delivery for cancer therapy R Tietze, J Zaloga, H Unterweger, S Lyer, RP Friedrich, C Janko, M Pöttler, ... Biochemical and biophysical research communications 468 (3), 463-470, 2015 | 468 | 2015 |
| Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity RP Friedrich, K Tepper, R Rönicke, M Soom, M Westermann, K Reymann, ... Proceedings of the National Academy of Sciences 107 (5), 1942-1947, 2010 | 374 | 2010 |
| Transcription factors Sox8 and Sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancy CC Stolt, P Lommes, RP Friedrich, M Wegner Oxford University Press for The Company of Biologists Limited 131 (10), 2349 …, 2004 | 274 | 2004 |
| Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils G Habicht, C Haupt, RP Friedrich, P Hortschansky, C Sachse, J Meinhardt, ... Proceedings of the National Academy of Sciences 104 (49), 19232-19237, 2007 | 272 | 2007 |
| Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammation LE Muñoz, R Bilyy, MHC Biermann, D Kienhöfer, C Maueröder, J Hahn, ... Proceedings of the National Academy of Sciences 113 (40), E5856-E5865, 2016 | 153 | 2016 |
| Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility J Zaloga, C Janko, J Nowak, J Matuszak, S Knaup, D Eberbeck, R Tietze, ... International journal of nanomedicine, 4847-4866, 2014 | 134 | 2014 |
| 670 nm laser light and EGCG complementarily reduce amyloid-β aggregates in human neuroblastoma cells: basis for treatment of Alzheimer's disease? AP Sommer, J Bieschke, RP Friedrich, D Zhu, EE Wanker, HJ Fecht, ... Photomedicine and laser surgery 30 (1), 54-60, 2012 | 87 | 2012 |
| Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake JM Poller, J Zaloga, E Schreiber, H Unterweger, C Janko, P Radon, ... International journal of nanomedicine, 3207-3220, 2017 | 85 | 2017 |
| Ménage-à-Trois: The Ratio of Bicarbonate to CO2 and the pH Regulate the Capacity of Neutrophils to Form NETs C Maueröder, A Mahajan, S Paulus, S Gößwein, J Hahn, D Kienhöfer, ... Frontiers in immunology 7, 583, 2016 | 83 | 2016 |
| Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods RP Friedrich, C Janko, M Poettler, P Tripal, J Zaloga, I Cicha, S Dürr, ... International journal of nanomedicine, 4185-4201, 2015 | 80 | 2015 |
| Iron oxide nanoparticles in regenerative medicine and tissue engineering RP Friedrich, I Cicha, C Alexiou Nanomaterials 11 (9), 2337, 2021 | 72 | 2021 |
| Expression of SoxE and SoxD genes in human gliomas B Schlierf, RP Friedrich, P Roerig, J Felsberg, G Reifenberger, M Wegner Neuropathology and applied neurobiology 33 (6), 621-630, 2007 | 67 | 2007 |
| Modulation of human IAPP fibrillation: cosolutes, crowders and chaperones M Gao, K Estel, J Seeliger, RP Friedrich, S Dogan, EE Wanker, R Winter, ... Physical Chemistry Chemical Physics 17 (13), 8338-8348, 2015 | 65 | 2015 |
| Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting J Zaloga, M Pöttler, G Leitinger, RP Friedrich, G Almer, S Lyer, E Baum, ... European Journal of Pharmaceutics and Biopharmaceutics 101, 152-162, 2016 | 59 | 2016 |
| The class III POU domain protein Brn-1 can fully replace the related Oct-6 during schwann cell development and myelination RP Friedrich, B Schlierf, ER Tamm, MR Bösl, M Wegner Molecular and cellular biology, 2005 | 58 | 2005 |
| Functionalization of T lymphocytes with citrate-coated superparamagnetic iron oxide nanoparticles for magnetically controlled immune therapy M Mühlberger, C Janko, H Unterweger, RP Friedrich, B Friedrich, J Band, ... International journal of nanomedicine, 8421-8432, 2019 | 56 | 2019 |
| Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models S Lugert, H Unterweger, M Mühlberger, C Janko, S Draack, F Ludwig, ... International journal of nanomedicine, 161-180, 2019 | 48 | 2019 |
| Synthesis and characterization of tissue plasminogen activator—functionalized superparamagnetic iron oxide nanoparticles for targeted fibrin clot dissolution S Heid, H Unterweger, R Tietze, RP Friedrich, B Weigel, I Cicha, ... International Journal of Molecular Sciences 18 (9), 1837, 2017 | 40 | 2017 |
